ZZZhen Zhang

Zhen Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhen Zhang has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Lei Yang

    Department of Nutrition, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    4 shared publications
  • Linyan Huang

    Department of Endocrinology Zhujiang Hospital, Southern Medical University Guangzhou Guangdong People's Republic of China

    4 shared publications
  • Baozhu Liang

    Department of Endocrinology and Metabolism, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    3 shared publications
  • Hong Chen

    Department of Endocrinology and Metabolism, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    3 shared publications
  • Jingxin Li

    Department of Endocrinology and Metabolism, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    3 shared publications
  • Xiaoyan Zhang

    Department of Endocrinology and Metabolism, Zhujiang Hospital, Southern Medical University, Guangzhou, China

    3 shared publications

Latest Publications

  • Comparative efficacy and safety of Glucagon‐like pepetide‐1 receptor agonists with metformin in Asian versus non‐Asian patients with type 2 diabetes: A systematic review and meta‐analysis

    by Wenxuan Li, Linyan Huang, Ruixue Wang, Peiyan Peng, Aowen Song, Yi Zeng, Zhen Zhang

    Aims: In type 2 diabetes, glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) in combination with metformin show better efficacy than metformin alone. Nevertheless, the reactions of different ethnic groups, especially Asian and non‐Asian populations, are still controversial. To give clinical medication usage an evidence‐based foundation, this meta‐analysis examined GLP‐1RAs' safety and efficacy when combined with metformin in the treatment of type 2 diabetes mellitus. Materials and Methods: Up to January 2025, systematic searches for randomised controlled trials were carried out in PubMed, Embase, the Cochrane Library, SinoMed and Wanfang comparing GLP‐1RA/metformin combination versus metformin alone in type 2 diabetes, with subgroup analyses for Asian versus non‐Asian cohorts. RevMan version 5.3 was used for analyses, and the Cochrane tools for risk of bias were used for quality assessment. Results: This meta‐analysis comprised 11 papers in total (6 Asian trials: 750 people; 5 non‐Asian trials: 1096 people). After treatment of GLP‐1RAs combined with metformin, the Asian group showed greater improvement in glycosylated haemoglobin (HbA1c) (weighted mean differences [WMD], −1.09; 95% confidence intervals [CI], −1.48 to −0.71; subgroup heterogeneity: I 2 = 77.7%, p < 0.05) and weight (WMD, −4.16; 95% CI −6.11 to −2.22; subgroup heterogeneity: I 2 = 89.5%, p < 0.05) with a lower gastrointestinal (GI) events risk (relative risks, 0.76; 95% CI, 0.47 to 1.22; subgroup heterogeneity: I 2 = 93.7%, p < 0.00001). There were no racial variations in fasting glucose levels ( p = 0.78) or hypoglycaemia ( p = 0.16). Conclusions: This meta‐analysis suggested potential ethnic variations in the treatment combining GLP‐1RAs with metformin, with Asian populations achieving superior HbA1c reduction and weight loss alongside better GI tolerance.

  • Open Access

    Identification of natural killer cell-characteristic genes in atherosclerosis based on bioinformatics analysis

    by Lei Yang, Huipeng Zhang, Linyan Huang, Ruixue Wang, Zhen Zhang, Yi Zeng

    Atherosclerosis (AS), a chronic inflammatory disease with autoimmune components, represents the predominant pathological change underlying cardiovascular diseases. Natural killer (NK) cells, pivotal actors in the innate immune system, play intricate regulatory roles in AS. Our objective was to identify and analyze NK cell-related genes involved in AS pathogenesis. We conducted differential expression analysis and functional enrichment analysis via microarray datasets from AS patients, identified NK cell-characteristic genes and performed subgroup analysis of AS on the basis of the expression levels of these genes. The results revealed that the differentially expressed genes in AS were predominantly associated with immune response activities and were significantly enriched in NK cell-mediated cytotoxicity pathways. PTPN6, ITGAL, TYROBP, SLAMF7, LCP2, HCST, HAVCR2, and VAV3 were identified as NK cell-characteristic genes. Subgroup analysis indicated that in patients with high expression levels of NK cell-characteristic genes, the progression of AS may be driven primarily by immune cell activity, whereas in those with low expression levels, TGF-β signaling may be the primary driving factor. In summary, our findings emphasize the crucial role of NK cell-mediated immunity in AS, offering potential targets for personalized immunomodulatory therapies and highlighting the need for tailored treatments based on different AS subtypes.


  • Open Access

    The comorbidity burden of diabetes and stroke: a retrospective study in Beijing, China

    by Linyan Huang, Jiadong Zeng, Ying Luo, Hanming Wang, Zhen Zhang, Yi Zeng

    The high costs associated with diabetes management, coupled with the increasing prevalence of comorbidities, present a significant challenge to China’s healthcare system, with cardiovascular complications being particularly prominent. The purpose of this study was to evaluate the comorbidities of diabetic patients with stroke in Beijing from 2016 to 2018 and the impact on treatment options and associated costs. This retrospective cohort study included diabetic patients enrolled in Beijing’s medical insurance with outpatient medical records. We compared comorbidities, medications, and related treatment costs between stroke and non-stroke patients. A representative sample of 2,853,036 patients with diabetes was identified from the data collected from 2016 to 2018, of which an average of 21.18% of patients reported stroke. A higher percentage of diabetic patients with stroke reported other comorbidities including hypertension, coronary artery disease, dyslipidemia, chronic respiratory disease, and osteoporosis as compared to those without stroke(all p’s < 0.0001). The costs increased dramatically if diabetic patients developed comorbidities, including hypertension, CAD, dyslipidemia, CRD, and osteoporosis. Annual costs of medications were higher for diabetic patients with stroke and any types of comorbidity compared to diabetic patients without stroke (p <.0001, respectively). More types of drugs were used for diabetic patients with stroke and any types of comorbidity. The needs of individuals with diabetes and stroke, including their comorbidity patterns and medical burdens, must be carefully taken into account. Health systems will need to address the increasing demand for diagnosing and managing comorbidities in individuals with diabetes and stroke.


  • Open Access

    Treatments, medical expenses and complications of hospital outpatient healthcare associated with stroke in patients with diabetes in China: a retrospective analysis of the Beijing Municipal Medical Insurance Database

    by Yi Zeng, SiTing Liang, Hanming Wang, JiaDong Zeng, Ying Luo, Weihao Wang, JingTao Qiao, Jingwen Fan, Zhen Zhang, Lixin Guo

    Objectives Diabetes is closely associated with risk of stroke and its adverse sequelae. Approximately 20%–33% of patients with stroke have diabetes. In China, however, it is unclear how stroke affects healthcare utilisation, medications and complications among people with diabetes. This study aimed to analyse the clinical characteristics, treatment options, medical expenses and complications of hospital outpatient healthcare associated with stroke in patients with diabetes in China. Design A retrospective, multicentre, observational study. Setting Beijing Municipal Medical Insurance Database, with data from 2016 to 2018. Participants The study included patients with diabetes whose data included 2016–2018 outpatient medication records and who had Beijing medical insurance. Patients who did not have continuous prescription records for more than 2 months were excluded from the analysis. In total, 2 853 036 people with diabetes were included, and patients who had and did not have a stroke were compared. Results In our study, 19.75%–22.30% of patients with diabetes suffered from stroke between 2016 and 2018. The average annual medical cost for a patient diagnosed with diabetes is ¥9606.65, and the cost increases to ¥13 428.39 when diabetes was combined with stroke; thus, stroke increases the medical cost for patients with diabetes by 39.78% (pConclusions Stroke is associated with a significant increase in complications and medications for patients with diabetes and greatly adds to the economic burden of these patients. Early identification of stroke risk factors in patients with diabetes, as well as targeted poststroke diabetes management, is crucial from a socioeconomic perspective for a comprehensive management and treatment of stroke in patients with diabetes.


  • Open Access

    A nomogram based on clinicopathological and ultrasound characteristics to predict central neck lymph node metastases in papillary thyroid cancer

    by Fei Chen, Shuiping Jiang, Fan Yao, Yixi Huang, Jiaxi Cai, Jia Wei, Chengxu Li, Yanxuan Wu, Xiaolin Yi, Zhen Zhang

    Purpose: Papillary thyroid cancer (PTC) has grown rapidly in prevalence over the past few decades, and central neck lymph node metastasis (CNLNM) is associated with poor prognoses. However, whether to carry out preventive central neck lymph node dissection (CNLND) is still controversial. We aimed to construct a prediction model of CNLNM to facilitate making clinical surgical regimens.Methods: A total of 691 patients with PTC between November 2018 and December 2021 were included in our study. Univariate and multivariate analyses were performed on basic information and clinicopathological characteristics, as well as ultrasound characteristics (American College of Radiology (ACR) scores). The prediction model was constructed and performed using a nomogram, and then discriminability, calibrations, and clinical applicability were evaluated.Results: Five variables, namely, male, age >55 years, clinical lymph node positivity, tumor size ≥1 cm, and ACR scores ≥6, were independent predictors of CNLNM in the multivariate analysis, which were eventually included to construct a nomogram model. The area under the curve (AUC) of the model was 0.717, demonstrating great discriminability. A calibration curve was developed to validate the calibration of the present model by bootstrap resampling, which indicated that the predicted and actual values were in good agreement and had no differentiation from the ideal model. The decision curve analysis (DCA) indicated that the prediction model has good clinical applicability.Conclusions: Our non-invasive prediction model combines ACR scores with clinicopathological features presented through nomogram and has shown good performance and application prospects for the prediction of CNLNM in PTCs.


  • Retracted
    Open Access

    Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery

    by Xiaoyan Zhang, Jingxin Li, Tiancai Liu, Min Zhao, Baozhu Liang, Hong Chen, Zhen Zhang

    Background. Few drugs are clearly available for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH); nevertheless, mounting studies have provided sufficient evidence that bariatric surgery is efficient for multiple metabolic diseases, including NAFLD and NASH, while the molecular mechanisms are still poorly understood. Methods. The mRNA expression profiling of GSE48452 and GSE83452 were retrieved and obtained from the Gene Expression Omnibus (GEO) database. The limma package was employed for identifying differentially expressed genes (DEGs), followed by clusterProfiler for performing Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, and GSEA software for performing GSEA analyses. The PPI network analyses were constructed using Metascape online analyses. WGCNA was also utilized to identify and verify the hub genes. CIBERSORT tools contributed to the analysis of immune cell infiltration of liver diseases. Results. We identify coexpressed differential genes including 10 upregulated and 55 downregulated genes in liver tissue after bariatric surgery. GO and KEGG enrichment analyses indicated that DEGs were remarkably involved in the immune response. GSEA demonstrated that DEGs were markedly enriched in the immune response before surgery, while most were enriched in metabolism after surgery. Seven genes were screened through the MCC algorithm and KME values, including SRGN, CD53, EVI2B, MPEG1, NCKAP1L, LCP1, and TYROBP. The mRNA levels of these genes were verified in the Attie Lab Diabetes Database, and only LCP1 was found to have significant differences and correlation with certain immune cells. Conclusion. Our knowledge of the mechanisms by which bariatric surgery benefits the liver and the discovery of LCP1 is expected to serve as potential biomarkers or therapeutic targets for NAFLD and NASH.


  • Open Access

    Association of the Coronavirus Disease 2019 Outbreak on the Diabetes Self-Management in Chinese Patients: An Analytical Cross-Sectional Study

    by Linyan Huang, Li Zhang, Shuiping Jiang, Baozhu Liang, Ningning Xu, Jingxin Li, Xiaoyan Zhang, Zhen Zhang

    Background: The coronavirus disease 2019 (COVID-19) outbreak has seriously affected people’s lives, especially those with chronic diseases. Diabetes self-management, which plays an important role in glycaemic control and reducing the risk of acute and long-term complications, may be discouraged by social distancing. Purpose: To evaluate the level of self-management activities in Chinese patients with type 2 diabetes mellitus (T2DM) during the COVID-19 pandemic. Patients and Methods: A survey of with 872 patients with T2DM in the inpatient and outpatient departments through face-to-face interviews was conducted from 1 July, 2020 to 30 September, 2020. The main outcome measures were glycaemic control status and level of self-management activities during the pandemic. Results: In terms of glycaemic control, the data showed that patients with fasting plasma glucose (FPG) < 7.0 mmol/L (36.4%), postprandial plasma glucose (PPG) < 10.0 mmol/L (26.3%), or glycosylated haemoglobin (HbA1c) < 7.0% (18.6%) in our investigation has well-controlled blood glucose level, and 11.9% of patients experienced blood glucose < 3.9 mmol/L during the outbreak. The diabetes self-management of Chinese patients decreased and the final diabetes self-management score of the Chinese patients was 3.4 ± 1.45. Patients with higher education, diabetes education, comorbidities, and online consultations had higher diabetes self-management scores (P < 0.05). Adherence to diabetes self-management in the normal glycaemic control group was higher than that in the substandard glycaemic control group (P< 0.05). Among all participants, 72.1% of the patients reduced the frequency of hospital visits, and 44.8% considered that they had diabetes-related stress during the pandemic. The mean anxiety level score rated by 286 patients was 5.3± 2.8. Conclusion: The COVID-19 pandemic has affected diabetes self-management, including substandard glycemic control, increased diabetes-related stress, limited exercise range and medical visits. Therefore, future interventions should focus on the online management of chronic diseases and support online consultation’ development and promotion, which can overcome physical distance and provide personalized services conveniently.


  • Open Access

    Dapagliflozin alleviates advanced glycation end product induced podocyte injury through AMPK/mTOR mediated autophagy pathway

    by Lei Yang, Baozhu Liang, Jingxin Li, Xiaoyan Zhang, Hong Chen, Jia Sun, Zhen Zhang


  • Open Access

    Reversal of angiotensin ll-induced β-cell dedifferentiation via inhibition of NF-κb signaling

    by Hong Chen, Wenjun Zhou, Yuting Ruan, Lei Yang, Ningning Xu, Rongping Chen, Rui Yang, Jia Sun, Zhen Zhang

    Type 2 diabetes mellitus (T2DM) is characterized by pancreatic β-cell failure, which arises from metabolic stress and results in β cell dedifferentiation, leading to β-cell death. Pathological activation of the renin–angiotensin system (RAS) contributes to increase cell stress, while RAS intervention reduces the onset of T2DM in high-risk populations and promotes insulin secretion in rodents. In this study, we investigated whether and how RAS induces β-cell dedifferentiation and the mechanism underlying this process. In vitro, with the methods of quantitative real-time reverse transcriptase-PCR (qRT-PCR) and western blotting, we examined the change of cell identity-related gene expression, progenitor like gene expression, cellular function, and nuclear factor kappa b (NF-κb) signaling activity in β cell lines after exposure to angiotensin II (AngII) and disruption of RAS. In vivo, parallel studies were performed using db/db mice. Related protein expression was detected by Immunofluorescence analysis. Activation of RAS induced dedifferentiation and impaired insulin secretion, eventually leading to β-cell failure. Mechanistically, Angll induced β-cell dedifferentiation via NF-κb signaling, while treatment with lrbesartan and sc-514 reversed the progenitor state of β cells. The present study found that RAS might induce β-cell dedifferentiation via angiotensin II receptor type 1 activation, which was promoted by NF-κb signaling. Therefore, blocking RAS or NF-kb signaling efficiently reversed the dedifferentiated status of β cells, suggesting a potential therapy for patients with type 2 diabetes.


  • Open Access

    GLP-1 ameliorates the proliferation activity of INS-1 cells inhibited by intermittent high glucose concentrations through the regulation of cyclins

    by Zhen Zhang, Jing Li, Xinkui Jiang, Lei Yang, Lei Lei, Dehong Cai, Hua Zhang, Hong Chen

    Glucagon-like peptide-1 (GLP-1) and its analog exendin (EX)-4 have been considered to promote β-cell growth and expansion. In the present, study we investigated the effect of GLP-1 on proliferative activity and cell cycle regulation in the pancreatic insulin-secreting β-cell line, INS-1, treated with intermittent high glucose. INS-1 cells were treated with normal glucose (5.5 mmol/l), constant high glucose (30 mmol/l) and intermittent high glucose (rotation/24 h in 5.5 or 30 mmol/l) in the presence or absence of GLP-1 (100 nmol/l) for seven days. Proliferative activity, cell cycle and the expression of cyclin D1, p21, p27 and Skp2 were examined. INS-1 treated with intermittent high glucose and GLP-1 demonstrated a significant increase in proliferation activity (1.45±0.12; P<0.01) and decreased cell proportion in G0/G1 phase (49.73±4.04%, P<0.01) compared with those without GLP-1. Furthermore, the expression levels of cyclin D1 and Skp2 were increased, while the expression of p27 and p21 were significantly reduced. Similar results were identified in those treated with constant high glucose and GLP-1. These results suggest that GLP-1 may ease the G0/G1 cell cycle arrest of INS-1 cells induced by intermittent high glucose by upregulating the expression of cyclin D1 and Skp2, downregulating the expression of p21 and p27, and finally promoting the cell cycle progression and proliferation activity.